DK0746545T3 - Nipecotinsyrederivater som antithrombotiske forbindelser - Google Patents

Nipecotinsyrederivater som antithrombotiske forbindelser

Info

Publication number
DK0746545T3
DK0746545T3 DK95914023T DK95914023T DK0746545T3 DK 0746545 T3 DK0746545 T3 DK 0746545T3 DK 95914023 T DK95914023 T DK 95914023T DK 95914023 T DK95914023 T DK 95914023T DK 0746545 T3 DK0746545 T3 DK 0746545T3
Authority
DK
Denmark
Prior art keywords
acid derivatives
antithrombotic compounds
nipecotinic acid
nipecotinic
compounds
Prior art date
Application number
DK95914023T
Other languages
English (en)
Inventor
Mary Pat Beavers
Patricia Andrade-Gordon
William J Hoekstra
Original Assignee
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp
Application granted granted Critical
Publication of DK0746545T3 publication Critical patent/DK0746545T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK95914023T 1994-03-16 1995-03-14 Nipecotinsyrederivater som antithrombotiske forbindelser DK0746545T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21377294A 1994-03-16 1994-03-16
US36489694A 1994-12-27 1994-12-27
PCT/US1995/003145 WO1995025091A2 (en) 1994-03-16 1995-03-14 Nipecotic acid derivatives as antithrombic compounds

Publications (1)

Publication Number Publication Date
DK0746545T3 true DK0746545T3 (da) 1999-11-08

Family

ID=26908383

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95914023T DK0746545T3 (da) 1994-03-16 1995-03-14 Nipecotinsyrederivater som antithrombotiske forbindelser

Country Status (20)

Country Link
US (1) US5770575A (da)
EP (1) EP0746545B1 (da)
JP (1) JPH09510453A (da)
KR (1) KR100328287B1 (da)
CN (1) CN1083834C (da)
AT (1) ATE180470T1 (da)
AU (1) AU703397B2 (da)
CA (1) CA2163027A1 (da)
DE (1) DE69509875T2 (da)
DK (1) DK0746545T3 (da)
ES (1) ES2131313T3 (da)
FI (1) FI113763B (da)
GR (1) GR3030566T3 (da)
HU (1) HUT74871A (da)
MX (1) MX9504800A (da)
NO (1) NO304885B1 (da)
NZ (1) NZ283209A (da)
RU (1) RU2135470C1 (da)
TW (1) TW318179B (da)
WO (1) WO1995025091A2 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2164109T3 (es) * 1993-09-22 2002-02-16 Fujisawa Pharmaceutical Co Derivados de n-(3-piperidinilcarbonil)-beta-alanina como antagonistas de paf.
CA2215106A1 (en) * 1995-03-17 1996-09-26 Fujisawa Pharmaceutical Co., Ltd. N-acylpiperidinylcarbonylaminocarboxylic acids and their use as glycoprotein iib/iiia antagonists and fibrinogen-blood platelets binding inhibitors
CA2248809A1 (en) * 1996-03-13 1997-09-18 Fujisawa Pharmaceutical Co., Ltd. N-[(r)-1-{3-(4-piperidyl)propionyl}-3-piperidylcarbonyl]-2(s)-acetylamino-beta-alanine as fibrinogen receptor antagonist
PT923555E (pt) * 1996-05-01 2005-09-30 Ortho Mcneil Pharm Inc Derivados carboxamida de pirrolidina, piperidina e hexa-hidroazepina para o tratamento de disturbios tromboticos
SI0923555T1 (en) * 1996-05-01 2005-10-31 Ortho-Mcneil Pharmaceutical, Inc. Carboxamide derivatives of pyrrolidine, piperidine and hexahydroazepine for the treatment of thrombosis disorders
DE19741235A1 (de) * 1997-09-18 1999-03-25 Hoechst Marion Roussel De Gmbh Neue Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
US6066651A (en) * 1997-10-29 2000-05-23 Ortho-Mcneil Pharmaceutical, Inc. Orally-active nipecotamide glycolamide esters for the treatment of thrombosis disorders
AU1415099A (en) * 1997-11-18 1999-06-07 Merck & Co., Inc. 4-substituted-4-piperidine carboxamide derivatives
US6020347A (en) * 1997-11-18 2000-02-01 Merck & Co., Inc. 4-substituted-4-piperidine carboxamide derivatives
YU74601A (sh) * 1999-03-22 2004-05-12 Ortho-Mcneil Pharmaceutical Inc., U.S. POSTUPAK ZA DOBIJANJE (S-(R*,S*)]-p-[[[1-OkSO-3-(4-PIPERIDINIL)PROPIL]-3-PIPERIDINIL]KARBONIL]AMINO]-3-PIPERIDINPROPIONSKE KISELINE I NJENIH DERIVATA
AUPQ570100A0 (en) 2000-02-17 2000-03-09 Fujisawa Pharmaceutical Co., Ltd. Beta-alanine derivatives and their use as receptor antagonists
EP2404899A1 (en) 2004-02-25 2012-01-11 Astellas Pharma Inc. Contrast medium for thrombus detection
EP3184149A1 (en) * 2015-12-23 2017-06-28 Julius-Maximilians-Universität Würzburg Soluble glycoprotein v for treating thrombotic diseases
CN109734655B (zh) * 2019-03-11 2020-06-02 都创(上海)医药科技有限公司 一种fkbp配体的同型二聚体合成工艺

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4857508A (en) * 1987-12-03 1989-08-15 Monsanto Company Novel platelet-aggregation inhibitor peptide derivatives
US5318899A (en) * 1989-06-16 1994-06-07 Cor Therapeutics, Inc. Platelet aggregation inhibitors
TW201303B (da) * 1990-07-05 1993-03-01 Hoffmann La Roche
IE912760A1 (en) * 1990-08-06 1992-02-12 Smith Kline French Lab Compounds
CA2117282A1 (en) * 1991-11-22 1993-05-27 Ofer Lider Non-peptidic surrogates of the arg-gly-asp sequence and pharmaceutical compositions comprosing them
US5219867A (en) * 1991-12-16 1993-06-15 Research Corporation Technologies, Inc. Platelet aggregation inhibitory agents
US5358934A (en) * 1992-12-11 1994-10-25 The United States Of America As Represented By The Secretary Of Agriculture Materials and methods for control of pests
US5559209A (en) * 1993-02-18 1996-09-24 The General Hospital Corporation Regulator regions of G proteins

Also Published As

Publication number Publication date
EP0746545A1 (en) 1996-12-11
FI955498A (fi) 1996-01-15
NO304885B1 (no) 1999-03-01
MX9504800A (es) 1997-05-31
HU9503270D0 (en) 1996-05-28
CA2163027A1 (en) 1995-09-21
FI113763B (fi) 2004-06-15
DE69509875T2 (de) 1999-12-09
NO954609L (no) 1996-01-05
AU703397B2 (en) 1999-03-25
NZ283209A (en) 1998-04-27
CN1128022A (zh) 1996-07-31
JPH09510453A (ja) 1997-10-21
GR3030566T3 (en) 1999-10-29
DE69509875D1 (de) 1999-07-01
AU2119195A (en) 1995-10-03
RU2135470C1 (ru) 1999-08-27
US5770575A (en) 1998-06-23
EP0746545B1 (en) 1999-05-26
FI955498A0 (fi) 1995-11-15
NO954609D0 (no) 1995-11-15
KR100328287B1 (ko) 2002-10-11
TW318179B (en) 1997-10-21
HUT74871A (en) 1997-02-28
WO1995025091A3 (en) 1995-10-12
WO1995025091A2 (en) 1995-09-21
ES2131313T3 (es) 1999-07-16
CN1083834C (zh) 2002-05-01
ATE180470T1 (de) 1999-06-15

Similar Documents

Publication Publication Date Title
NO971538L (no) Purin- og guaninforbindelser som inhibitorer for PNP
TR199700844T1 (xx) Pirazolil-Benzoil T�revleri.
AU1973997A (en) Pentafluorobenzenesulfonamides and analogs
DK0746545T3 (da) Nipecotinsyrederivater som antithrombotiske forbindelser
NO963370L (no) Nye mercaptoacetylamido-1,3,4,5-tetrahydrobenzo[cÅazepin-3-on-disulfidderivater som er anvendbare som inhibitorer av enkefalinase og ACE
EA200000826A1 (ru) Галоидированные производные амидиноаминокислот, применимые в качестве ингибиторов no-синтазы
EA200000204A1 (ru) Производные пирролопирролона в качестве ингибиторов эластазы нейтрофилов
NO972887D0 (no) Piperidineddiksyrederivater anvendelige som fibrinogen-antagonistmiddel
DK0937043T3 (da) Substituerede tetrahydropyridin-derivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse derivater
FI963168A (fi) Enkefalinaasin inhibiittoreina käyttökelpoisia uusia indaani-2-merkaptoasetyyliamiddisulfidijohdannaisia
AU686104B2 (en) Substituted amidinonaphthyl ester derivatives
CA2183320A1 (en) Novel Mercaptoacetylamide Disulfide Derivatives Useful as Inhibitors of Enkephalinase and Ace
NO960271L (no) Tiokarbamoylforbindelser anvendt som mikrobiocider
MX9603450A (es) Procedimiento para la obtencion de aminotriazolinas substituidas.
NO950212L (no) Indolinyl-N-hydroksyurinstoff- og -N-hydroksamsyrederivater som lipoksygenase-inhibitorer
NO20012328L (no) Fluorerte 3,4-dihydrokinolinderivater anvendt som NOS- inhibitorer